Baicalin alleviates bleomycin-induced early pulmonary fibrosis in mice via the mitoKATP signaling pathway

M Han, S Wang, X Zhou, P Zhang, Z Han, Y Chen… - Toxicology, 2023 - Elsevier
Bleomycin (BLM), a frequently employed chemotherapeutic agent, exhibits restricted clinical
utility owing to its pulmonary toxicity. Meanwhile, baicalin (BA)—an active ingredient …
被引用次数：2 相关文章

Baicalin alleviates bleomycin-induced early pulmonary fibrosis in mice via the mitoKATP signaling pathway

M Han, S Wang, X Zhou, P Zhang, Z Han… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Bleomycin (BLM), a frequently employed chemotherapeutic agent, exhibits restricted clinical
utility owing to its pulmonary toxicity. Meanwhile, baicalin (BA)-an active ingredient extracted …

Baicalin alleviates bleomycin-induced early pulmonary fibrosis in mice via the mitoKATP signaling pathway.

M Han, S Wang, X Zhou, P Zhang, Z Han, Y Chen… - Toxicology, 2023 - europepmc.org
Bleomycin (BLM), a frequently employed chemotherapeutic agent, exhibits restricted clinical
utility owing to its pulmonary toxicity. Meanwhile, baicalin (BA)-an active ingredient extracted …

Baicalin alleviates bleomycin-induced early pulmonary fibrosis in mice via the mitoKATP signaling pathway

M Han, S Wang, X Zhou, P Zhang, Z Han… - …, 2023 - ui.adsabs.harvard.edu
Bleomycin (BLM), a frequently employed chemotherapeutic agent, exhibits restricted clinical
utility owing to its pulmonary toxicity. Meanwhile, baicalin (BA)—an active ingredient …